The program, serving patients from rheumatology, dermatology, gastroenterology, allergy, and cardiology clinics, is the first of its kind within the Veterans Health Administration, researchers said.
Integrating specialty pharmacists into health systems may help promote safe and effective use of biologic treatment, say newly published findings from a Veterans Health Administration (VHA) hospital.
The data from the first year of the centralized specialty medication management (CSMM) service implemented various interventions for appropriate use of treatment, as well as quick identification and intervention for serious adverse effects.
Their program, explained the researchers, is the first of its kind within the VHA and shows the feasibility of the service, with a high retention rate among the 54 patients. Patients were enrolled from rheumatology, allergy, cardiology, dermatology, and gastroenterology clinics. The researchers noted that there was lower enrollment than expected, largely due to the COVID-19 pandemic.
“As the CSMM clinic has grown, there has been more uptake, and [clinical pharmacist practitioners] are now generally seeing 4-7 patients per half day. To date, 165 patients have been seen, and 42 patients have successfully completed the planned CSMM service monitoring and have been discharged,” detailed the researchers. “There are approximately 100-120 patients managed by the CSMM service at any given time. The service continues to manage a high proportion of patient on adalimumab, though alirocumab, benralizumab, and dupilumab have increased in use.”
The researchers largely attributed the feasibility of the program to scheduling support, access to the electric medical records, a patient identification process, and communication for improving specialist provider awareness.
Among the cohort included in the analysis, there were 160 clinical outcomes documented throughout the year. The researchers noted that while injection technique corrections and medication changes or discontinuations made by the pharmacists were not the most common interventions, they were more consequential. The researchers underscored that there was no control group included in their study, causing uncertainty around which outcomes would have occurred without the service.
“Other more clerical interventions, such as ensuring appropriate injection supplies, refill assistance, and safe needle disposal, should not be overlooked as they also ensure safe medication use and have been shown to be an important component of the specialty pharmacist role,” explained the researchers. “However, the most consequential interventions were likely the early identification and intervention after the emergence of serious adverse effects. While this occurred less frequently, the introduction of early close CPP monitoring may have prevented longer lasting ramifications for these individuals.”
Administrative assistance (34%), such as having alcohol swaps at their disposal, and medication assistance (9%), such as filling refills on time, were common throughout the year.
Reference
Albright T, Simonet R, Bollom E, et al. Feasibility of a centralized specialty biologic medication management clinic at a VA hospital. J Am Pharm Assoc. 2022;62(5):1694-1699
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More